Webinar to be held Tuesday, December 2nd, at 8:00 am ETREDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage ...
Specifically, the team is hoping to create seaweed-based housings to replace traditional petroleum plastics without changing the way such diagnostic lateral flow tests work. To accomplish this, the ...
The global phycoerythrin market is anticipated to grow from USD 5.18 million in 2025 to approximately USD 11.30 million by ...
Glownetics, a biotechnology-driven skincare brand, has officially launched its advanced At Home Vampire Facial system—bringing one of the beauty industry’s most coveted treatments directly to ...
Opportunities in the Molecular Biology Enzymes Reagents and Kits market include rising R&D investments and growing demand for ...
Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...
The global phycoerythrin market is on track to nearly double in value over the next decade, increasing from USD 5.18 million ...
In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.
Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
Opinion
7dOpinion
This CEO Just Sold His Company for $21 Billion. It Wouldn’t Have Happened Without Federally Funded Research
When companies do solve that puzzle, the rewards can be huge: As Modern CEO went to press, Exact Sciences announced it was selling to Abbott in a deal valued at $21 billion.
DNAHelix leverages the IPG subsidiary’s expertise in healthcare and science communications as well as its considerable work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback